FDA Lifts Hold on Diabetes-Treatment Trials
US FDA lifts clinical hold on Biomea's diabetes trials after safety review
The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for type 1 and type 2 diabetes, the drug developer said on Thursday. The regulator had placed a hold on two trials of its lead drug,
Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up
Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing
Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials
Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,
US FDA lifts clinical hold on Biomea's diabetes trials
Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies
Shares of Biomea Fusion BMEA gained 9.1% on Thursday after the FDA lifted the clinical hold it had earlier placed on the company’s ongoing early to mid-stage studies evaluating its lead candidate, BMF-219,
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.
BLACK ENTERPRISE Empowers Black Men: Prostate Cancer In The Black Community And The Importance Of Clinical Trials
Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...
New Atlas1d
Synapse-restoring pill set for human trials as novel schizophrenia treatment
Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...
The Trump Trials: A motion to rescue
The latest news in Donald Trump’s four criminal cases, including more delays and a mammoth legal filing due on Thursday from ...
AstraZeneca in AI collaboration with Immunai to inform cancer drug trials
AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...
OCTC students host Salem Witch Trials exhibit
Students at Owensboro Community and Technical College (OCTC) have pulled together an art exhibit worthy of the Halloween ...
devdiscourse1d
WHO Releases New Guidance to Enhance Clinical Trials and Improve Global Health Equity
Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...
‘Agatha All Along’ Episode 3 Recap: “Through Many Miles of Tricks and Trials”
Boy Kills World’ on Hulu, a Hyperviolent Comix-Meets-Video Games Revenge Flick Starring Bill Sarsgard 'The Penguin' Series ...
Counting Africa In For Clinical Trials
Pharma leaders need to consider the lack of diversity in clinical trial findings and the resulting dearth of therapies ...